scholarly journals Cationic lipid-mediated intracellular delivery of antibodies into live cells

BioTechniques ◽  
2008 ◽  
Vol 44 (7S) ◽  
pp. vii-xi ◽  
Author(s):  
Claire O. Weill ◽  
Stéphanie Biri ◽  
Patrick Erbacher
2020 ◽  
Vol 59 (41) ◽  
pp. 18087-18094 ◽  
Author(s):  
Shaojun Yang ◽  
Qiao Tang ◽  
Long Chen ◽  
Jin Chang ◽  
Tian Jiang ◽  
...  

2016 ◽  
Vol 34 (1) ◽  
pp. 161-174 ◽  
Author(s):  
Ruth Röder ◽  
Jonas Helma ◽  
Tobias Preiß ◽  
Joachim O. Rädler ◽  
Heinrich Leonhardt ◽  
...  

2020 ◽  
Author(s):  
Fengqian Chen ◽  
Qi Liu ◽  
Terrell Hilliard ◽  
Tingzeng Wang ◽  
Hongjun Liang ◽  
...  

AbstractThe human kinome contains >500 protein kinases, and regulates up to 30% of the proteome. Kinase study is currently hindered by a lack of in vivo analysis approaches due to two factors: our inability to distinguish the kinase reaction of interest from those of other kinases in live cells and the cell impermeability of the ATP analogs. Herein, we tackled this issue by combining the widely used chemical genetic method developed by Dr. Kevan Shokat and colleagues with nanoparticle-mediated intracellular delivery of the ATP analog. The critical AKT1 protein kinase, which has been successfully studied with the method, was used as our initial prototype. Briefly, enlargement of the ATP binding pocket, by mutating the gate-keeper Methionine residue to a Glycine, prompted the mutant AKT1 to preferentially use the bulky ATP analog N6-Benzyl-ATP-γ-S (A*TPγS) and, thus, differentiating AKT1-catalyzed and other phosphorylation events. The lipid/calcium/phosphate (LCP) nanoparticle was used for efficient intracellular delivery of A*TPγS, overcoming the cell impermeability issue. The mutant, but not wild-type, AKT1 used the delivered A*TPγS for autophosphorylation and phosphorylating its substrates in live cells. Thus, an in vivo protein kinase analysis method has been developed. The strategy should be widely applicable to other protein kinases.


2016 ◽  
Vol 4 (12) ◽  
pp. 1773-1780 ◽  
Author(s):  
Sarah A. Altınoğlu ◽  
Ming Wang ◽  
Kathleen Q. Li ◽  
Yuyang Li ◽  
Qiaobing Xu

The PTEN tumor suppressor protein encapsulated in cationic lipid-like nanoparticles as a direct treatment approach for PTEN-deficient cancer cells.


2013 ◽  
Vol 24 (20) ◽  
pp. 205101 ◽  
Author(s):  
Krishnakiran Medepalli ◽  
Bruce W Alphenaar ◽  
Robert S Keynton ◽  
Palaniappan Sethu

2005 ◽  
Vol 107 (2) ◽  
pp. 276-287 ◽  
Author(s):  
James Heyes ◽  
Lorne Palmer ◽  
Kaz Bremner ◽  
Ian MacLachlan

2012 ◽  
Vol 27 (1) ◽  
pp. 98-108 ◽  
Author(s):  
Irene Canton ◽  
Marzia Massignani ◽  
Nisa Patikarnmonthon ◽  
Luca Chierico ◽  
James Robertson ◽  
...  

2020 ◽  
Vol 132 (41) ◽  
pp. 18243-18250
Author(s):  
Shaojun Yang ◽  
Qiao Tang ◽  
Long Chen ◽  
Jin Chang ◽  
Tian Jiang ◽  
...  

2018 ◽  
Vol 9 (27) ◽  
pp. 5967-5975 ◽  
Author(s):  
Lele Sun ◽  
Yanjing Gao ◽  
Yaoguang Wang ◽  
Qin Wei ◽  
Jiye Shi ◽  
...  

A DNA-programmed membrane fusion strategy for directing intracellular delivery of proteins into live cells.


Sign in / Sign up

Export Citation Format

Share Document